Coloplast A/S
CSE:COLO B
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Axel Mark Inc
TSE:3624
|
JP |
|
O
|
Ortivus AB
STO:ORTI B
|
SE |
|
Caihong Display Devices Co Ltd
SSE:600707
|
CN |
|
Indian Wood Products Co Ltd
BSE:540954
|
IN |
|
C
|
Chongqing Water Group Co Ltd
SSE:601158
|
CN |
|
Solitario Zinc Corp
TSX:SLR
|
US |
|
Grupo Financiero Banorte SAB de CV
BMV:GFNORTEO
|
MX |
|
G
|
Global Mastermind Capital Ltd
HKEX:905
|
HK |
|
Hunan Sundy Science and Technology Co Ltd
SZSE:300515
|
CN |
Operating Margin
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
Peer Comparison
| Country | Company | Market Cap |
Operating Margin |
||
|---|---|---|---|---|---|
| DK |
|
Coloplast A/S
CSE:COLO B
|
94.9B DKK |
Loading...
|
|
| JP |
|
Hoya Corp
TSE:7741
|
10T JPY |
Loading...
|
|
| CH |
|
Alcon AG
SIX:ALC
|
29.7B CHF |
Loading...
|
|
| US |
M
|
Medline Inc
NASDAQ:MDLN
|
37B USD |
Loading...
|
|
| US |
|
Align Technology Inc
NASDAQ:ALGN
|
12.4B USD |
Loading...
|
|
| UK |
|
ConvaTec Group PLC
LSE:CTEC
|
4.6B GBP |
Loading...
|
|
| JP |
A
|
Asahi Intecc Co Ltd
TSE:7747
|
937.4B JPY |
Loading...
|
|
| CA |
|
Bausch + Lomb Corp
NYSE:BLCO
|
5.8B USD |
Loading...
|
|
| CN |
|
Intco Medical Technology Co Ltd
SZSE:300677
|
38.9B CNY |
Loading...
|
|
| CN |
|
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
|
36.4B CNY |
Loading...
|
|
| US |
|
Lantheus Holdings Inc
NASDAQ:LNTH
|
5.2B USD |
Loading...
|
Market Distribution
| Min | -5 981.6% |
| 30th Percentile | 1.3% |
| Median | 7.5% |
| 70th Percentile | 16.3% |
| Max | 423.3% |
Other Profitability Ratios
Coloplast A/S
Glance View
Coloplast A/S, headquartered in Humlebæk, Denmark, has a storied history that dates back to 1954 when a nurse, Elise Sørensen, identified a crucial need in the healthcare sector. Her sister had undergone ostomy surgery, and the lack of appropriate post-operative care products inspired Sørensen to design the world’s first adhesive ostomy bag. This innovation laid the groundwork for Coloplast's trajectory in the healthcare industry. Today, the company has expanded its focus to include ostomy care, continence care, wound and skin care, and interventional urology. With a commitment to improving patients' quality of life, Coloplast has become a leader in designing and manufacturing products that not only highlight practicality but also embody comfort and discretion. Coloplast generates revenue through a business model that emphasizes product innovation and direct engagement with healthcare providers and patients. The company invests significantly in research and development to improve and widen its product offerings continuously. It operates globally, distributing its products directly and via partnerships with hospitals, clinics, and healthcare professionals. By maintaining an attentive approach to user experience and incorporating customer feedback into its development processes, Coloplast ensures its portfolio aligns with the actual needs of its users. This user-centered strategy not only enhances customer loyalty but also fortifies the company’s market position, driving its financial success.
See Also
Operating Margin is calculated by dividing the Operating Income by the Revenue.
The current Operating Margin for Coloplast A/S is 27.3%, which is below its 3-year median of 27.5%.
Over the last 3 years, Coloplast A/S’s Operating Margin has decreased from 29.9% to 27.3%. During this period, it reached a low of 26.9% on Dec 31, 2024 and a high of 29.9% on Dec 31, 2022.